Completed PHASE3 INTERVENTIONAL NCT00322413

Comparison of Epoetin Alfa and Epoetin Omega in Anemic Dialysis Patients:Results of Efficacy Trial

Efficacy and Safety of Epoetin Omega in Patients Undergoing Regular Dialysis. Part II: Comparative Trial Versus Epoetin Alfa

Sponsor: General Hospital Sveti Duh

Conditions End Stage Renal Disease Regular Dialysis Treatment Renal Anemia

Interventions Epoetin

Updated 5 times since 2017 Last updated: Jul 20, 2006 Started: Jan 31, 1997 Completion: Apr 30, 1997

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates End Stage Renal Disease and Regular Dialysis Treatment and is currently completed. General Hospital Sveti Duh leads this study, which shows 5 recorded versions since 1997 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Jan 1997

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

General Hospital Sveti Duh

Data source: General Hospital Sveti Duh

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Zagreb, Croatia